Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy

Update your browser to view ScienceDirect.

Request details:

Request ID: 8ed856759fe11032-LAX
IP: 101.37.83.79
UTC time: 2024-12-06T01:00:13+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4